{"schema_version":"secwatch.filing_event.v1","accession":"0001000694-24-000003","form_type":"8-K","ticker":"NVAX","cik":"0001000694","company_name":"NOVAVAX INC","filed_at":"2024-01-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.023453+00:00","generated_at":"2026-06-06T12:36:48.350602+00:00","sec_items":["2.05"],"event_type":"other_material","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Novavax to cut ~12% of global workforce; expects $4-7M restructuring charge in Q1 2024","bullets":["Board approved ~12% global workforce reduction (9% of FTEs; remainder contractors/consultants).","One-time severance and benefit charge estimated at $4M to $7M, primarily in Q1 2024.","Resulting workforce expected to be ~30% lower vs. end of Q1 2023.","Full annual cost savings expected in 2025; ~85% of annual impact realized in 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001000694-24-000003","json":"https://secwatch.observer/filing/0001000694-24-000003.json","markdown":"https://secwatch.observer/filing/0001000694-24-000003.md","text":"https://secwatch.observer/filing/0001000694-24-000003.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1000694/000100069424000003/0001000694-24-000003-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1000694/000100069424000003/nvax-20240130.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T12:36:48.350602+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}